NEW BRUNSWICK, N.J., May 19, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceuticalsbusiness for the investment community beginning at 9:00 a.m. (Eastern Time) on Thursday, May 26, 2011 at The Heldrich Hotel, in New Brunswick, N.J. ending at
Sheri McCoy, Vice Chairman, Executive Committee, and Pharmaceuticals Worldwide Chairmen Joaquin Duato and Paul Stoffels, M.D. will host the meeting and discuss the role the segment plays in the Company's overall business and growth strategy. The meeting will also feature presentations from the five therapeutic area leaders in the Pharmaceuticals research and development organization.
Investors and other interested parties may access this meeting by visiting the Company's website at www.investor.jnj.com for a simultaneous webcast of the presentations.
A replay and podcast will be available shortly after the live webcast through www.investor.jnj.com.
SOURCE Johnson & Johnson
Subscribe to our Free Newsletters!
Bubonic plague is an infectious disease caused by the bacteria Yersinia pestis present in rodents ...
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...
Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...View All